Loading...
Angiogenesis inhibitors increase tumor stem cells
The clinical efficacy of angiogenesis inhibitors targeting the vascular endothelial growth factor pathway has recently been met with numerous phase III failures that showed modest survival benefits. Understanding the resistance mechanisms of antiangiogenic therapy is essential to overcoming the limi...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Landes Bioscience
2012
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3408967/ https://ncbi.nlm.nih.gov/pubmed/22441817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.19852 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|